NOV 20, 2019 4:49 PM PST

Harnessing the Power of Natural Killer Cells to Fight Cancer

WRITTEN BY: Kara Marker

Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results investigating the cells in mice, and scientists show that human cells share the same promising physiological responses.

NK cells (brown) patrolling between cells of a healthy human lymph node. Source: Institute of Pathology, University of Bern

NK cells (brown) patrolling between cells of a healthy human lymph node. Source: Institute of Pathology, University of Bern

 

Natural killer (NK) cells are key components of the innate immune system, the arm of human immunity that responds first to pathogenic invasions with a non-specific attack. That attack could be via virus or cancer, but either way, NK cells seek to eliminate affected cells before the affliction has a chance to spread. They can do this one of two ways: release cell toxins for a direct kill, or activate cells affected by cancer or virus to self-destruct, a process called apoptosis.

During a viral invasion, NK cells manage T cells of the adaptive immune system, the second, more specific phase of immune response, by preventing them from unnecessarily killing host cells unaffected by the virus. NK cells do this by releasing “messenger molecules” to support immune defense.

But scientists from the recent study are presently more interested in NK cell-induced cellular self-destruction and its potential ability to improve anti-cancer clinical tactics. Researchers put “death ligands” under the microscope, scrutinizing these surface proteins’ abilities of interacting with “corresponding receptors” on the surface of target cells. One death ligand stood out during the study, a protein called “tumor necrosis factor-related apoptosis-inducing ligand,” or “TRAIL.”

Cancerous cells are more sensitive to TRAIL stimulation than healthy cells, making TRAIL-related therapies potential options for initiating the apoptotic self-destruction of cancer cells. One roadblock seems to stand in the way: in past studies, TRAIL has also been associated with negative health outcomes in particular infection cases. The present study offers a solution for navigating around this roadblock to effectively utilize TRAIL as an anti-cancer tactic.

Researchers began by studying the TRAIL response in a murine model of viral infection. Mice whose NK cells did not have TRAIL were better equipped to fight the virus than mice whose TRAIL was fully intact. NK cells perceived cellular signaling differently when they lacked TRAIL; they did less killing and more messenger molecule production, and T cells subsequently became more protective and were able to better remove virally infected cells. Researchers saw signs of similar activity in human NK cells too, indicating a potential for the reprogramming of NK cells to better target cancerous cells in addition to virally infected cells.

Sources: University of Bern, European Molecular Biology Organization (EMBO) Reports

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 17, 2020
Immunology
A Peanut a Day Keeps Allergies Away
DEC 17, 2020
A Peanut a Day Keeps Allergies Away
Canadian researchers have made a breakthrough for children with peanut allergies: immunotherapy that when taken daily fo ...
JAN 12, 2021
Immunology
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
JAN 12, 2021
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
The first organ transplant—performed over 60 years ago—was a success because the donor and recipient were id ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
JAN 28, 2021
Immunology
Killers With a Hit on the Spike
JAN 28, 2021
Killers With a Hit on the Spike
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...
FEB 10, 2021
Immunology
Cross-Reactive Antibodies Don't Protect Against COVID
FEB 10, 2021
Cross-Reactive Antibodies Don't Protect Against COVID
Did you know that hundreds of viruses can cause the common cold? Rhinovirus, adenovirus, and coronavirus infections can ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
Loading Comments...